---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-032871"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2024-02-13T23:59:59+00:00"
generated_at: "2026-06-06T03:18:19.629761+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Aileron approves $204K bonus for President/COO Brian Windsor for FY 2023

## Summary
- Board approved a $204,375 performance-based cash bonus for Brian Windsor (President and COO) for FY 2023.
- The bonus updates Windsor's 2023 Summary Compensation Table; total compensation becomes $289,642.
- No other named executive officers received a performance-based cash bonus for FY 2023.

## SEC filing metadata
- accession: 0001193125-24-032871
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2024-02-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312524032871/0001193125-24-032871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312524032871/d780523d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-032871
- JSON: https://secwatch.observer/filing/0001193125-24-032871.json
- Plain text: https://secwatch.observer/filing/0001193125-24-032871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.